Ignite Creation Date:
2025-12-25 @ 2:05 AM
Ignite Modification Date:
2026-02-20 @ 6:21 PM
Study NCT ID:
NCT01423760
Status:
TERMINATED
Last Update Posted:
2016-10-06
First Post:
2011-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Common Safety Follow-up Trial of Tecemotide (L-BLP25)
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01
Start Date Type:
None
Primary Completion Date:
2015-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2011-08-23
First Submit QC Date:
None
Study First Post Date:
2011-08-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-06-02
Results First Submit QC Date:
None
Results First Post Date:
2016-10-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-08-10
Last Update Post Date:
2016-10-06
Last Update Post Date Type:
ESTIMATED